Increasing evidences indicate that
2-Methoxyestradiol (2ME2) plays an essential role in protecting against inflammatory responses. However, its effect on
IgG immune complex (IC)-induced
acute lung injury (ALI) remains enigmatic. In the study, by using i.p. administration of 2ME2, we evaluated its influence on
IgG IC-induced
pulmonary injury in mice. We found that during
IgG IC-induced ALI, mice treated by 2ME2 displayed a substantial decrease in vascular permeability and neutrophil influx (represented by
myeloperoxidase activity) when compared with their counterparts receiving vehicle treatment. Furthermore, 2ME2 treatment significantly decreased pro-inflammatory mediator production and inflammatory cell, especially neutrophil accumulation in bronchoalveolar lavage fluids (BALFs) upon
IgG IC stimulation. In vitro,
IgG IC-triggered inflammatory mediator production was markedly down-regulated by 2ME2 in macrophages. Moreover, we verified that the activation of the
transcription factors, NF-κB and
CCAAT/enhancer-binding protein (C/EBP) β, were inhibited by 2ME2 in
IgG IC-challenged macrophages. We demonstrated that alleviation of NF-κB-dependent transcription might be associated with reduced phosphorylation of NF-κB p65, and reduction of C/EBP activation was directly linked to its expression. In addition, we discovered that
IgG IC-stimulated phosphorylation of both
p38 MAPK and ERK1/2 was alleviated by 2ME2. These data indicated a novel strategy for blockade of
IgG IC-induced inflammatory activities.